The ROE as of September 2024 (TTM) for Lantheus Holdings, Inc. (LNTH) is 49.15%

According to Lantheus Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 49.15%. This represents a change of 282.05% compared to the average of 12.87% of the last 4 quarters.

Lantheus Holdings, Inc. (LNTH) Historical ROE (quarterly & annually)

How has LNTH ROE performed in the past?

The mean historical ROE of Lantheus Holdings, Inc. over the last ten years is 62.71%. The current 49.15% ROE has changed -21.62% with respect to the historical average. Over the past ten years (40 quarters), LNTH's ROE was at its highest in in the December 2017 quarter at 417.01%. The ROE was at its lowest in in the December 2022 quarter at -26.65%.

Lantheus Holdings, Inc. (LNTH) ROE by Quarter and Year

Discovering the peaks and valleys of Lantheus Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lantheus Holdings, Inc. (LNTH) Average ROE

How has LNTH ROE performed in the past?

The current ROE of Lantheus Holdings, Inc. (LNTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Lantheus Holdings, Inc. (LNTH) ROE vs. Peers

How is LNTH’s ROE compared to its peers?

Lantheus Holdings, Inc.’s ROE is less than Neurocrine Biosciences, Inc. (14.86%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), greater than Ironwood Pharmaceuticals, Inc. (-2.78%), less than Alkermes plc (22.66%), greater than Avadel Pharmaceuticals plc (-122.60%), less than ANI Pharmaceuticals, Inc. (0%), less than Dr. Reddy's Laboratories Limited (6.02%), less than Collegium Pharmaceutical, Inc. (20.28%), less than Pacira BioSciences, Inc. (49.14%), less than Alvotech (7.32%), less than Catalent, Inc. (86.54%), greater than Amphastar Pharmaceuticals, Inc. (-26.99%), less than Journey Medical Corporation (25.42%), less than Aquestive Therapeutics, Inc. (5.44%), less than Dynavax Technologies Corporation (36.59%), less than null (2.76%),

Build a custom stock screener for Lantheus Holdings, Inc. (LNTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantheus Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lantheus Holdings, Inc. (LNTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lantheus Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.